The Glucose-Lowering Potential of Exenatide Delivered Orally via Goblet Cell- Targeting Nanoparticles

Permeation of Insulin, Calcitonin and Exenatide across Caco-2 Monolayers: Measurement Using a Rapid, 3-Day System

(2013) Vivek Gupta et al.   PLoS One

The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo

(2011) Ho-Ngoc Nguyen et al.   BIOMATERIALS

Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport

(2011) Yun Jin et al.   BIOMATERIALS

Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes

(2011) Yu Xiang et al.   JOURNAL OF CONTROLLED RELEASE

Chitosan—A versatile semi-synthetic polymer in biomedical applications

(2011) M. Dash et al.   PROGRESS IN POLYMER SCIENCE

Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection

(2010) Kiran Sonaje et al.   BIOMATERIALS

Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery

(2010) Emilie Roger et al.   Nanomedicine

The evolving place of incretin-based therapies in type 2 diabetes

(2010) Baptist Gallwitz   PEDIATRIC NEPHROLOGY

Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration

(2008) Bronislava R. Gedulin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells

(2008) S KANG et al.   JOURNAL OF BIOTECHNOLOGY

A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice

(2008) Cheng-Hao Jin et al.   JOURNAL OF CONTROLLED RELEASE